Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 803 matches for

An internationally recognised centre of excellence for biomedical and clinical research and teaching

Transformative treatments for children with fatal genetic lung diseases

AlveoGene, a company co-founded by two of our scientists, today moves closer to approval of its novel inhaled gene therapy for a rare deficiency which causes fatal respiratory distress syndrome in newborns.

University of Oxford unveils new vaccine development partnership

Oxford Cancer, the Oxford Vaccine Group and the Pandemic Sciences Institute have announced a new collaboration with Belgian Biotech Innovator, Univercells.

Improvements to children’s surgery to be identified with the help of the NHS DigiTrials participant recruitment service

Researchers at Oxford Population Health’s National Perinatal Epidemiology Unit and ten children’s surgical hospitals across England and Scotland will use a service provided by NHS DigiTrials to investigate whether care and outcomes could be improved for children who have six conditions that usually need complex surgery shortly after birth.

Launch of the new BHF Oxford Centre of Research Excellence

Celebrating a £5million British Heart Foundation renewal award to the University of Oxford to advance cardiovascular science.

Outsourcing adult social care has contributed to England’s care crisis, argue researchers

Outsourcing adult social care services in England to the private sector since the 1980s has led to worse care and should be rolled back, argue researchers from the Blavatnik School of Government and the Department of Social Policy and Intervention, Oxford University, in The British Medical Journal today. They suggest that removing the profit motive would help improve quality and reduce inequities.

Men more willing than women to accept robot care in old age, Oxford study finds

A new study from AI experts at the University of Oxford and University of Melbourne reveals that men are much more likely to support the idea of being cared for in their homes by a robot when they are infirm or elderly, than women.

Treating bullying as everyone’s problem reduces incidence in primary schools

The largest trial of its kind in the UK has shown how a low-cost, structured, anti-bullying programme can improve social dynamics in primary schools and reduce victimisation.

Largest ever UK study reveals stark ethnic and social inequalities in lung cancer diagnosis

The most comprehensive study ever conducted of lung cancer diagnosis in England has revealed significant disparities between ethnic groups and striking evidence that people living in the most deprived areas were diagnosed with lung cancer at twice the rate of those in affluent areas.

Oxford space lab experiment heads to International Space Station

The first human tissue samples from Oxford's Space Innovation Lab (SIL) have been launched and are on their way to the International Space Station, where they will be used to study the effects of space microgravity on the human ageing process.

Discovery of key mechanism in Huntington’s Disease could pave the way for early detection and treatment

Researchers from the University of Oxford have identified a key biochemical mechanism relevant to the development of Huntington’s Disease. This discovery opens up the possibility of studying the disease before its clinical onset and eventually stopping its progression.

Ineos Oxford Institute awards over £2m to innovative projects to tackle antimicrobial resistance

The Ineos Oxford Institute for antimicrobial research (IOI) has awarded over £2m to six projects across the University of Oxford focused on developing new solutions to tackle antimicrobial resistance (AMR).

Akerman group study describes first new all-optical tool for quantifying inhibitory receptor driving forces

A new paper from the Akerman group, published in the journal Nature Communications this week, explains the development of a new ‘ORCHID’ (Optical Reporting of CHloride Ion Driving) biosensor to measure the driving force acting on inhibitory receptors in the brain.

New Minichiello research explores the role of cell dysfunction in ataxic symptoms

A new study from the Minichiello group, published recently in the journal Biology, has shown that dysfunction in BDNF-TrkB signalling, restricted to a specific subset of cerebellar granule cells, is sufficient to generate ataxic symptoms

35 Years of the MRC WIMM- Medical Research Council Weatherall Institute of Molecular Medicine

In 1989, Sir David Weatherall founded the Institute of Molecular Medicine to bridge the gap between basic science and clinical medicine. To mark 35 years since the MRC WIMM opened its labs, we're looking back on some of our highlights and achievements.

Cellular roadmap reveals new paths to treating inflammatory bowel disease

In a world first, researchers at the Kennedy Institute, Oxford have mapped the cellular dynamics following treatment with the most commonly used advanced therapy in autoimmune diseases. They have discovered why some patients benefit from this therapy while others do not, potentially paving the way for new therapies.

New Type 1 Diabetes Grand Challenge funding to develop drugs from bugs

Today the Type 1 Diabetes Grand Challenge, a trailblazing partnership between the Steve Morgan Foundation, Diabetes UK, and Breakthrough T1D (formerly JDRF) has announced funding for a cutting-edge research project led by researchers in the Radcliffe Department of Medicine, which could bring us closer to a cure for type 1 diabetes.

Study Publishes New Insights on Goblet Cell Differentiation in Colorectal Cancer

The Oncology Department at the University of Oxford is excited to announce the forthcoming publication in the Proceedings of the National Academy of Sciences (PNAS) of the research paper “Goblet Cell Differentiation Subgroups in Colorectal Cancer.” This groundbreaking study sheds light on the role of goblet cell differentiation in colorectal cancer (CRC) and its impact on cancer progression and prognosis.

Typhoid vaccine trial confirms sustained protection for older children

A single dose of typhoid conjugate vaccine (TCV) offers safe, effective protection against typhoid two years after vaccination in all children, and sustained protection for older children at three to five years post immunisation, according to a report by researchers at the Oxford Vaccine Group and the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b). But it also shows a decline in protection at the later timepoints among children vaccinated at younger ages.

New research network unites Oxford University’s global fight against antimicrobial resistance

A new University-wide network on antimicrobial resistance aims to generate novel research and collaborations to tackle one of the most urgent global health threats.

Oxford researchers secure funding for world's first ovarian cancer prevention vaccine

Researchers have been awarded funding from Cancer Research UK to create the world’s first vaccine to prevent ovarian cancer.

Load More